Bayesian Capital Management, LP Biomarin Pharmaceutical Inc Transaction History
Bayesian Capital Management, LP
- $788 Million
- Q4 2024
A detailed history of Bayesian Capital Management, LP transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Bayesian Capital Management, LP holds 11,100 shares of BMRN stock, worth $719,834. This represents 0.09% of its overall portfolio holdings.
Number of Shares
11,100
Previous 20,822
46.69%
Holding current value
$719,834
Previous $1.46 Million
50.17%
% of portfolio
0.09%
Previous 0.17%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
635Shares Held
183MCall Options Held
2.07MPut Options Held
1.72M-
Black Rock Inc. New York, NY22.7MShares$1.47 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.26 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.18 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$956 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$843 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.1B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...